Status:
COMPLETED
Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Tourette Syndrome in Adolescence
Tourette Syndrome
Eligibility:
All Genders
13-17 years
Brief Summary
Investigators propose a cross-sectional, observational pilot study to examine the contribution of stress, family dynamics, and peer relationships to quality of life (QOL) in adolescents with Tourette ...
Detailed Description
Tourette syndrome (TS) is a multi-faceted neurodevelopmental disorder with wide-ranging impact on adolescent quality of life (QOL). Comorbid psychiatric and psychological factors exert greater influen...
Eligibility Criteria
Inclusion
- Inclusion Criteria for adolescents with TS:
- adolescent age 13-17 years of age
- adolescent diagnosis of Tourette syndrome (TS)
- English-speaking adolescent and caregiver (as validated questionnaires are in English)
- adolescent and caregiver willingness and ability to complete relevant questionnaires
- Exclusion Criteria for adolescents with TS:
- cognitive or attentional impairment precluding ability of adolescent or caregiver to complete self-report questionnaires
- adolescent diagnosis of genetic conditions besides TS and its known comorbidities
- adolescent with severe medical conditions unrelated to TS (e.g. uncontrolled seizures, prominent heart conditions)
- Inclusion Criteria for adolescents without any neurologic or psychiatric diagnoses:
- adolescent age 13-17 years of age
- no history of tics
- English-speaking adolescent and caregiver
- adolescent and caregiver willingness and ability to complete relevant questionnaires
- Exclusion Criteria for adolescents without any neurologic or psychiatric diagnoses:
- cognitive or attentional impairment precluding ability of adolescent or caregiver to complete self-report questionnaires
- adolescent with severe medical conditions
Exclusion
Key Trial Info
Start Date :
March 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04449003
Start Date
March 29 2021
End Date
February 10 2023
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232-5400